Metabolon Seals $13.1M Series D

Metabolon Inc., a Durham, N.C.-based provider of biomarker discovery and analysis, has raised $13.1 million in Series D financing. New investor Keating Capital Inc. joins existing investors including Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght and Fulcrum Financial Partners.

30 August 2011•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail